KOTASOVÁ, Hana, Michaela CAPANDOVÁ, Vendula PELKOVÁ, Jana DUMKOVÁ, Zuzana SUMBALOVÁ KOLEDOVÁ, Ján REMŠÍK, Karel SOUČEK, Zuzana GARLÍKOVÁ, Veronika SEDLÁKOVÁ, Anas RABATA, Petr VAŇHARA, Lukáš MORÁŇ, Lukáš PEČINKA, Volodymyr POROKH, Martin KUČÍREK, Libor STREIT, Josef HAVEL and Aleš HAMPL. Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells. TISSUE ENGINEERING AND REGENERATIVE MEDICINE. SEOUL: KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC, 2022, vol. 19, No 5, p. 1033-1050. ISSN 1738-2696. Available from: https://dx.doi.org/10.1007/s13770-022-00458-0.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells
Authors KOTASOVÁ, Hana (203 Czech Republic, belonging to the institution), Michaela CAPANDOVÁ (203 Czech Republic, belonging to the institution), Vendula PELKOVÁ (203 Czech Republic, belonging to the institution), Jana DUMKOVÁ (203 Czech Republic, belonging to the institution), Zuzana SUMBALOVÁ KOLEDOVÁ (703 Slovakia, belonging to the institution), Ján REMŠÍK (703 Slovakia, belonging to the institution), Karel SOUČEK (203 Czech Republic, belonging to the institution), Zuzana GARLÍKOVÁ (203 Czech Republic, belonging to the institution), Veronika SEDLÁKOVÁ (203 Czech Republic, belonging to the institution), Anas RABATA (760 Syrian Arab Republic, belonging to the institution), Petr VAŇHARA (203 Czech Republic, belonging to the institution), Lukáš MORÁŇ (203 Czech Republic, belonging to the institution), Lukáš PEČINKA (203 Czech Republic, belonging to the institution), Volodymyr POROKH (804 Ukraine, belonging to the institution), Martin KUČÍREK (203 Czech Republic, belonging to the institution), Libor STREIT (203 Czech Republic, belonging to the institution), Josef HAVEL (203 Czech Republic, belonging to the institution) and Aleš HAMPL (203 Czech Republic, guarantor, belonging to the institution).
Edition TISSUE ENGINEERING AND REGENERATIVE MEDICINE, SEOUL, KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC, 2022, 1738-2696.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 20602 Medical laboratory technology ;
Country of publisher Republic of Korea
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.600
RIV identification code RIV/00216224:14110/22:00126034
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s13770-022-00458-0
UT WoS 000807342200001
Keywords in English Lung; Epithelium; hESC; Differentiation; Foregut endoderm
Tags 14110128, 14110517, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 14/3/2023 07:13.
Abstract
Background The progenitors to lung airway epithelium that are capable of long-term propagation may represent an attractive source of cells for cell-based therapies, disease modeling, toxicity testing, and others. Principally, there are two main options for obtaining lung epithelial progenitors: (i) direct isolation of endogenous progenitors from human lungs and (ii) in vitro differentiation from some other cell type. The prime candidates for the second approach are pluripotent stem cells, which may provide autologous and/or allogeneic cell resource in clinically relevant quality and quantity. Methods By exploiting the differentiation potential of human embryonic stem cells (hESC), here we derived expandable lung epithelium (ELEP) and established culture conditions for their long-term propagation (more than 6 months) in a monolayer culture without a need of 3D culture conditions and/or cell sorting steps, which minimizes potential variability of the outcome. Results These hESC-derived ELEP express NK2 Homeobox 1 (NKX2.1), a marker of early lung epithelial lineage, display properties of cells in early stages of surfactant production and are able to differentiate to cells exhibitting molecular and morphological characteristics of both respiratory epithelium of airway and alveolar regions. Conclusion Expandable lung epithelium thus offer a stable, convenient, easily scalable and high-yielding cell source for applications in biomedicine.
Links
MUNI/A/1390/2020, interní kód MUName: Analytická a fyzikální chemie ve výzkumu biologických, geologických a syntetických materiálů (Acronym: BIOGEOSYNT)
Investor: Masaryk University
MUNI/A/1398/2021, interní kód MUName: Zdroje pro tkáňové inženýrství 12 (Acronym: TissueEng 12)
Investor: Masaryk University
MUNI/A/1689/2020, interní kód MUName: Zdroje pro tkáňové inženýrství 11 (Acronym: TissueEng 11)
Investor: Masaryk University
NV16-31501A, research and development projectName: Tkáňové inženýrství epitelů: Buňky a protokoly pro regenerativní medicínu
ROZV/28/LF23/2020, interní kód MUName: Objasněni vlivu ztráty TUSC3 na změnu fenotypových vlastnosti buněk ovariálního povrchového epitelu.
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 20/7/2024 02:21